KAPA

Kairos Pharma, LTD.

$0.37 +0.00 (+0.54%) At close · Jul 2

Market Cap

$7.92M

21,411,198

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2025-10-08	Singhvi Rahul	Director	Award	19,084	—	—	49,204
2025-10-08	Murali Ramachandran	VP of Research and Development	Award	152,672	—	—	299,529
2025-10-08	Samuelson Doug	Chief Financial Officer	Award	152,672	—	—	293,039
2025-10-08	Bhowmick Neil	Chief Scientific Officer	Award	171,756	—	—	1,311,739
2025-10-08	Keyoung Hansoo Michael	Director	Award	19,084	—	—	29,084
2025-10-08	Bae Hyun W.	Director	Award	19,084	—	—	73,370
2025-10-08	Yu John S	Director, CEO and Chairman, 10% Owner	Award	190,840	—	—	230,105
2025-09-16	Keyoung Hansoo Michael	Director	Award	10,000	—	—	10,000
2025-09-16	Bae Hyun W.	Director	Award	10,000	—	—	54,286
2025-01-01	Murali Ramachandran	VP of Research and Development	Award	14,000	—	—	147,057
2025-01-01	Yu John S	Director, CEO and Chairman, 10% Owner	Award	14,000	—	—	5,355,838
2025-01-01	Bhowmick Neil	Chief Scientific Officer	Award	14,000	—	—	1,139,983
2024-11-25	Murali Ramachandran	VP of Research and Development	Buy	200	$1.59	$318	133,057
2024-11-22	Samuelson Doug	Chief Financial Officer	Buy	2,500	$1.50	$3,750	60,796
2024-11-20	Yu John S	Director, CEO and Chairman, 10% Owner	Buy	4,000	$1.44	$5,760	5,341,837

Showing 1–15 of 15 transactions

Key facts CIK 1962011 CUSIP 48301N104 Visit website Investor relations